Circ‐PDZD8 promotes cell growth and glutamine metabolism in non‐small cell lung cancer by enriching LARP1 via sequestering miR‐330‐5p
暂无分享,去创建一个
[1] J. Rao,et al. Circular RNA circGSK3B Promotes Cell Proliferation, Migration, and Invasion by Sponging miR-1265 and Regulating CAB39 Expression in Hepatocellular Carcinoma , 2020, Frontiers in Oncology.
[2] Xiaoming Gu,et al. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis , 2020, Journal of experimental & clinical cancer research : CR.
[3] Tiantuo Zhang,et al. circRNA-miRNA-mRNA regulatory network in human lung cancer: an update , 2020, Cancer Cell International.
[4] P. Meng,et al. circRNA-miRNA-mRNA regulatory network in human lung cancer: an update , 2020, Cancer Cell International.
[5] M. Taheri,et al. Non-coding RNA profile in lung cancer. , 2020, Experimental and molecular pathology.
[6] Qi Wang,et al. Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer , 2019, Journal of Cancer Research and Clinical Oncology.
[7] Y. Ke,et al. circPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma , 2019, Journal of Experimental & Clinical Cancer Research.
[8] Zheng Li,et al. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression. , 2019, Biochemical and biophysical research communications.
[9] Q. Pan,et al. CircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and Glutaminolysis , 2019, Theranostics.
[10] P. Adriaensens,et al. Glutamine Addiction and Therapeutic Strategies in Lung Cancer , 2019, International journal of molecular sciences.
[11] S. Xiao,et al. miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling , 2018, Oncogenesis.
[12] Jing Pan,et al. LncRNA DGCR5 contributes to CSC‐like properties via modulating miR‐330‐5p/CD44 in NSCLC , 2018, Journal of cellular physiology.
[13] Baohua Sun,et al. Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis , 2018, Journal of Cancer Research and Clinical Oncology.
[14] R. Chen,et al. LARP1 is regulated by the XIST/miR-374a axis and functions as an oncogene in non-small cell lung carcinoma. , 2017, Oncology reports.
[15] Shaomin Li,et al. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer. , 2017, Oncology reports.
[16] S. K. Yoon,et al. MicroRNA-330-5p negatively regulates ITGA5 expression in human colorectal cancer. , 2016, Oncology reports.
[17] Ming-Ming Wei,et al. Long Non-coding RNAs and Their Roles in Non-small-cell Lung Cancer , 2016, Genom. Proteom. Bioinform..
[18] Sadaf Ghaem-Maghami,et al. The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer , 2015, Nucleic acids research.
[19] Francesco Petrella,et al. Non-small-cell lung cancer , 2015, Nature Reviews Disease Primers.
[20] A E Willis,et al. LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression , 2014, Oncogene.
[21] Liang Peng,et al. LARP1 predict the prognosis for early-stage and AFP-normal hepatocellular carcinoma , 2013, Journal of Translational Medicine.
[22] John M. Asara,et al. Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.
[23] Ping Yang,et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. , 2008, Mayo Clinic proceedings.
[24] Rui Xin,et al. A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer. , 2018, American journal of cancer research.
[25] Yongsheng Li,et al. Computational Identification of Cross-Talking ceRNAs. , 2018, Advances in experimental medicine and biology.